Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Biocryst Pharmaceuticals Inc
About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. The RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older. Its portfolio also includes navenibart, which is a late-stage, long-acting plasma kallikrein inhibitor. It has also obtained an early-stage program for atopic dermatitis, STAR0310.
Find out what a historical investment in Biocryst Pharmaceuticals Inc would be worth today using our BCRX stock calculator.
Market Capitalisation
$2.23B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.57M
High today
$8.97
Low today
$8.72
Open price
$8.78
52-week high
$11.31
52-week low
$6.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy BCRX shares in Australia?
Buying BCRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Biocryst Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BCRX
What is the ticker symbol of Biocryst Pharmaceuticals Inc?
The ticker symbol for Biocryst Pharmaceuticals Inc is BCRX.
How much is one share of BCRX?
One share of BCRX is valued at $8.76 as of 20 May 2026.
What is the market capitalisation of Biocryst Pharmaceuticals Inc BCRX?
As of 20 May 2026 Biocryst Pharmaceuticals Inc has a market cap of $2.23B.
What is the 52-week high for Biocryst Pharmaceuticals Inc stock?
The Biocryst Pharmaceuticals Inc 52-week high stock price is $11.31.
What is the 52-week low for Biocryst Pharmaceuticals Inc stock?
The Biocryst Pharmaceuticals Inc 52-week low stock price is $6.00.
Can I buy BCRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BCRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BCRX on Stake
- Buy BCRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BCRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BCRX related stocks